CPRT three-lens brief
Evidence-based stock research on CPRT. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 9.5pp over 30 days. · Trading at 4% of its 52-week range — deep in the lower band.
- Trading at 4% of its 52-week range — deep in the lower band.
- Underperforming SPY by 9.5pp over 30 days.
- Analyst mean target $42.67 — 28% above current (9 analysts).
CPRT closed at $33.42 (+0.45%) as of 2026-05-04. Market cap: $32.19B. P/E (trailing) 21.0. Positives: analyst mean target $42.67 — 28% above current (9 analysts).. Concerns: trading at 4% of its 52-week range — deep in the lower band.; underperforming SPY by 9.5pp over 30 days.. Last quarter: Revenue $1.12B, net income $350.73M, free cash flow $1.04B.
Why three lenses on CPRT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CPRTacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CPRT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CPRT brief"></iframe>